学龄儿童及青少年甲状腺乳头状癌转移淋巴结数量的预后价值:多中心真实世界研究
该多中心回顾性队列研究纳入中国12个核医学科486例接受全甲状腺切除和放射性碘治疗的学龄儿童及青少年甲状腺乳头状癌患者,评估转移淋巴结数量对持续性疾病的影响。在N1b患者中,转移淋巴结数量是持续结构性疾病的独立危险因素,ROC分析确定≥14枚为预测切点;N1a患者中未见关联。
要点
- N1b型学龄儿童及青少年甲状腺乳头状癌中,转移淋巴结数量是持续结构性疾病的独立危险因素。
- 转移淋巴结数量≥14枚为预测持续结构性疾病的ROC分析切点。
- N1a型患者中转移淋巴结数量与持续性疾病无关联。
核心结论
- 转移淋巴结数量是与持续性疾病相关的主要因素,将其定量评估纳入风险分层可能改善N1b型学龄儿童及青少年甲状腺乳头状癌的管理。
研究设计与样本
- 多中心回顾性队列研究,纳入中国12个核医学科接受全甲状腺切除和放射性碘治疗的学龄儿童及青少年甲状腺乳头状癌患者486例,其中N1a 115例、N1b 371例。
主要发现
- 在N1b型患者中,转移淋巴结数量作为连续变量是持续结构性疾病的独立危险因素(HR:1.06;95% CI:1.01-1.11)。
- 转移淋巴结数量第三四分位组(16-22枚)持续结构性疾病风险增加(HR:3.35;95% CI:1.13-9.97;P=0.029)。
- 转移淋巴结数量第四四分位组(>22枚)持续结构性疾病风险增加(HR:5.52;95% CI:1.59-19.13;P=0.007)。
- ROC分析确定≥14枚转移淋巴结为预测持续结构性疾病的切点。
- 在N1a型患者中,转移淋巴结数量与持续性疾病无关联。
关键数值与推荐
- N1b型患者转移淋巴结数量第三四分位为16-22枚,第四四分位为>22枚。
- ROC分析确定的预测持续结构性疾病的转移淋巴结数量切点为≥14枚。
临床怎么用
- 对N1b型学龄儿童及青少年甲状腺乳头状癌患者,应定量评估转移淋巴结数量以辅助风险分层。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: How metastatic nodal burden influences the prognosis of school-age children and adolescents (SACAs) with papillary thyroid cancer (PTC) remains unclear. We investigated the independent impact of numerical metastatic nodal burden on clinical outcomes in these patients. MATERIALS AND METHODS: This multicenter retrospective cohort study included SACAs with PTC aged 18 years and older who had undergone total thyroidectomy and radioiodine therapy across 12 nuclear medicine departments in China. Persistent biochemical and structural diseases were evaluated. The independent role of metastatic nodes in persistent disease was evaluated using Cox proportional hazards regression. RESULTS: In total, 486 SACAs with PTC were analyzed, of whom 115 had N1a and 371 had N1b. Among SACAs with N1b PTC, a higher number of metastatic lymph nodes, analyzed as a continuous variable, was identified as an independent risk factor for persistent structural disease (HR: 1.06; 95% CI: 1.01-1.11). When analyzed as a categorical variable, patients in the third (16-22 nodes) and fourth (>22 nodes) quartiles of the number of metastatic nodes exhibited an increased hazard of persistent structural disease (HR: 3.35; 95% CI: 1.13-9.97; P =0.029 and HR: 5.52; 95% CI: 1.59-19.13; P =0.007, respectively). ROC analysis identified a cutoff of ≥14 metastatic lymph nodes for predicting persistent structural diseases. However, for SACAs with N1a PTC, analysis of the number of metastatic nodes revealed no association with persistent disease. CONCLUSIONS: The number of metastatic nodes is a predominant factor associated with persistent disease, and incorporating quantitative assessment of metastatic nodes may improve risk stratification in SACAs with N1b PTC.
引用
- Xiao L, Chang W, Feng H, et al. Prognostic Value of Number of Metastatic Nodes in School-Age Children and Adolescents With Papillary Thyroid Cancer: A Real-Life Multicenter Study. Clin Nucl Med. 2026. PMID: 42525679. doi:10.1097/RLU.0000000000006547
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。